Gonadotropin-Releasing Hormone Agonist (GnRH-a) Therapy Alters Activity of Plasminogen Activators, Matrix Metalloproteinases, and Their Inhibitors in Rat Models for Adhesion Formation and Endometriosis: Potential GnRH-a–Regulated Mechanisms Reducing Adhesion Formation 11Supported in part by grants HD29026 (K.L.S.-T.) and HD 273995 (T.E.C.) from the National Institutes of Health, Bethesda, Maryland. Additional support provided by TAP Pharmaceuticals, Inc., Deerfield, Illinois.
1998 ◽
Vol 69
(5)
◽
pp. 916-923
◽
1995 ◽
Vol 63
(5)
◽
pp. 1094-1100
◽
1999 ◽
Vol 82
(2)
◽
pp. 219-222
◽
1987 ◽
Vol 47
(4)
◽
pp. 710-713
◽
1996 ◽
Vol 3
(2)
◽
pp. 161A
1998 ◽
Vol 46
(3)
◽
pp. 202-205
◽
2005 ◽
Vol 84
◽
pp. S465-S466
◽
2009 ◽
Vol 91
(5)
◽
pp. 1909-1913
◽